TARGET THERAPY FOR DISSEMINATED CANCER OF THE CERVIX UTERI

The paper gives recent data on the use of target agents, such as erlotinib, gefitinib, cetuximab, bevacizumab, and sorafinib in advanced cancer of the cervix uteri (CCI). Approaches using target drugs in combination with chemotherapy are of the greatest interest. A spec- trum of molecular biomarkers...

Full description

Saved in:
Bibliographic Details
Main Authors: V. A. Gorbunova, A. v Odintsova, S. V. Khokhlova
Format: Article
Language:Russian
Published: ABV-press 2014-09-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/329
Tags: Add Tag
No Tags, Be the first to tag this record!